Press release
Diabetic Macular Edema Market Growth Analysis Highlighting Anti-VEGF Corticosteroid Therapies Intravitreal Injections and Implants Across Global Regions
Diabetic Macular Edema Market
Global Diabetic Macular Edema Market Size is valued at USD 4.04 billion in 2025 and is predicted to reach USD 4.74 billion by the year 2035 at a 1.7% CAGR during the forecast period for 2026 to 2035.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2895
Diabetic Macular Edema (DME) is a progressive retinal disorder characterized by fluid accumulation in the macula due to damage to the retinal microvasculature, commonly associated with diabetes. While early-stage DME may be asymptomatic, untreated progression can lead to significant visual impairment. Given the rising global prevalence of diabetes, demand for effective therapeutic interventions for DME is expected to increase steadily over the forecast period.
Market expansion is primarily driven by the widespread adoption of established anti-VEGF therapies, including aflibercept, bevacizumab, and ranibizumab, which continue to constitute the standard of care. Additionally, substantial investments in research and development, improvements in healthcare infrastructure, and increasing disposable incomes are creating favorable conditions for market growth.
Leading industry participants are actively pursuing innovative treatment modalities, further enhancing revenue potential. Moreover, government initiatives aimed at improving access to care and raising awareness of DME are anticipated to support market expansion and strengthen the overall industry outlook.
List of Prominent Players in the Diabetic Macular Edema Market:
• Novartis AG
• Bayer AG
• Allergen Plc.
• F. Hoffmann-La Roche Ltd.
• Alimera Sciences Inc.
• Valeant Pharmaceuticals International, Inc.
• KalVista Pharmaceuticals
• Genentech
• Oxurion
• Ocugen, Inc
• Regeneron Pharmaceuticals, Inc.
• Clearside Biomedical
• Daiichi Sankyo
• Arctic Vision
• Chugai Pharmaceutical Co., Ltd.
• Sanofi
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Lupin
• Allergan
• Merck & Co., Inc.
• Pfizer Inc.
• GlaxoSmithKline plc
• IRIDEX Corporation
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics
Growth Drivers:
The global Diabetic Macular Edema (DME) market is primarily driven by the rising prevalence of diabetes and ongoing advancements in therapeutic technologies. Increasing demand for effective treatment options among diabetic patients is expected to significantly enhance market revenues. Additionally, expanded research and development efforts aimed at improving the efficacy, accessibility, and affordability of DME therapies are anticipated to support sustained growth over the forecast period.
Challenges:
Despite favorable growth prospects, several challenges persist. Limited patient awareness of DME and a shortage of skilled healthcare professionals, particularly in emerging markets, continue to restrict widespread treatment adoption. The high cost of therapies also remains a significant barrier for both patients and healthcare systems. Furthermore, the COVID-19 pandemic adversely impacted the market by disrupting supply chains, restricting patient access to care, and temporarily halting manufacturing operations due to public health measures and lockdowns.
Regional Insights:
North America is projected to maintain its position as the largest regional market for DME, driven by a growing diabetic population, extensive research and development initiatives, and the presence of major industry stakeholders. Europe also represents a significant share of the market, supported by well-established healthcare infrastructure and rapid adoption of advanced therapeutic solutions. Strategic collaborations and proactive initiatives by leading companies are expected to strengthen regional market presence and create sustained growth opportunities over the forecast period.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2895
Segmentation of Diabetic Macular Edema Market-
By Drug Type-
• Anti-VEGF
o Ranibizumab (Lucentis)
o Aflibercept (Eylea)
• Corticosteroid Therapies
o Dexamethasone (Ozurdex)
o Fluocinolone Acetonide (Iluvien)
• Others
By Form-
• Intravitreal Injections
• Intravitreal Implants
By Distribution Channel-
• Hospitals
• Specialty Clinics
• Mail Order Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/diabetic-macular-edema-market/2895
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Macular Edema Market Growth Analysis Highlighting Anti-VEGF Corticosteroid Therapies Intravitreal Injections and Implants Across Global Regions here
News-ID: 4357038 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
CTCL Cutaneous T-Cell-Lymphoma Market Drivers Challenges and Opportunities Relat …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CTCL (Cutaneous T-Cell-Lymphoma) Market- (By Type (Mycosis Fungoides (MF), Sézary Syndrome (SS), And Other Related Diseases), By Therapy (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transplantation, And Others), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Other)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2035."
CTCL (Cutaneous T-Cell-Lymphoma) Market is predicted to grow at a 2.0%…
Credit Card Payments Market Research on Opportunities Challenges and Innovations …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Credit Card Payments Market Size, Share & Trends Analysis Report By Card Type (General Purpose Credit Cards and Specialty & Other Credit Cards), Application (Food & Groceries, Health & Pharmacy, Restaurants & Bars, Consumer Electronics, Media & Entertainment, Travel & Tourism and Others), and Provider (Visa, MasterCard, and Others)- Market Outlook And Industry Analysis 2035"
Credit…
Carpal Tunnel Release Systems Market Review on Competitive Landscape, Key Player …
The Carpal Tunnel Release Systems Market Size is valued at 776.07 Million in 2025 and is predicted to reach 2,534.41 Million by the year 2035 at a 13.2% CAGR during the forecast period for 2026 to 2035.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1024
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global carpal tunnel release systems market are:
• Increasing older population
• Increasing healthcare expenditure
• Technological developments…
Autoinjectors Market Forecast to Reach USD 4.7 Billion by 2034 Amid Increasing A …
Global Autoinjector Market Size is valued at USD 1.19 Bn in 2025 and is predicted to reach USD 4.98 Bn by the year 2035 at a 16.2% CAGR during the forecast period for 2026 to 2035.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1234
An autoinjector is a prefilled syringe equipped with a spring-loaded needle that delivers a precise dose of medication automatically upon activation. These devices are commonly…
More Releases for Diabetic
Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
